Expert Opinion on Pharmacotherapy

Spinocerebellar degeneration
pp. 1637-1641(5)
Author: Perlman S.L.

Pharmacotherapy for personality disorders
pp. 1643-1649(7)
Authors: Newton-Howes G.; Tyrer P.

Pharmacotherapy of postpartum psychosis
pp. 1651-1658(8)
Author: Sharma V.

Towards the pharmacotherapy of eating disorders
pp. 1659-1678(20)
Authors: Pederson K.J.; Roerig J.L.; Mitchell J.E.

Pharmacotherapy to limit weight gain caused by antipsychotic use
pp. 1679-1686(8)
Authors: Malhi G.S.; Mitchell P.B.

Current trends in fibromyalgia research
pp. 1687-1695(9)
Author: Marcus D.A.

Combination strategies for pain management
pp. 1697-1708(12)
Authors: Raffa R.B.; Clark-Vetri R.; Tallarida R.J.; Wertheimer A.I.

Central nervous system abnormalities in migraine
pp. 1709-1715(7)
Author: Marcus D.A.

Cannabinoids reduce symptoms of Tourette’s syndrome
pp. 1717-1725(9)
Authors: Müller-Vahl K.R.

Current treatment options for restless legs syndrome
pp. 1727-1738(12)
Authors: Wetter T.C.; Winkelmann J.; Eisensehr I.

Pharmacological management of narcolepsy
pp. 1739-1746(8)
Authors: Lammers G.J.; Overeem S.

Rationale for current therapies in Parkinson’s disease
pp. 1747-1761(15)
Authors: Romrell J.; Fernandez H.H.; Okun M.S.

Pharmacotherapy of iron overload in thalassaemic patients
pp. 1763-1774(12)
Authors: Ceci A.; Felisi M.; De Sanctis V.; De Mattia D.

Assessing the cost-effectiveness of switching from a -blocker to latanoprost in the treatment of ocular hypertension
pp. 1775-1788(14)
Authors: Costagliola C.; Parmeggiani F.; Sebastiani A.

The epidemiology of severe sepsis syndrome and its treatment with recombinant human activated protein C
pp. 1789-1799(11)
Authors: Doig C.J.; Laupland K.B.; Zygun D.A.; Manns B.J.

Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity
pp. 1801-1808(8)
Authors: Broughton S.; Greenough A.

Current treatment options to prevent perinatal transmission of herpes simplex virus
pp. 1809-1819(11)
Authors: Leung D.T.; Sacks S.L.

Current pharmacotherapy for the treatment of chronic hepatitis B
pp. 1821-1827(7)
Authors: Lagget M.; Rizzetto M.

Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies
pp. 1829-1838(10)
Authors: Stein D.J.; Davidson J.; Seedat S.; Beebe K.

Amoxicillin/clavulanate potassium extended release tablets: a new antimicrobial for the treatment of acute bacterial sinusitis and community-acquired pneumonia
pp. 1839-1846(8)
Author: Benninger M.S.

Gatifloxacin in community-acquired respiratory tract infection
pp. 1847-1855(9)
Author: Sethi S.

Is memantine a breakthrough in the treatment of moderate-to-severe Alzheimer’s disease?
pp. 1857-1860(4)
Author: Doggrell S.

Corrigendum
pp. 1887-1888(2)